Thermo Fisher Scientific Inc. TMO
NYSE
| 09/26/2026 | 06/27/2026 | 03/28/2026 | 12/31/2025 | 09/27/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.72B | 1.74B | 1.65B | 1.96B | 1.62B |
| Total Depreciation and Amortization | 825.00M | 819.00M | 734.00M | 728.00M | 661.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 47.00M | -5.00M | -81.00M | 318.00M | 66.00M |
| Change in Net Operating Assets | -43.00M | -425.00M | -1.11B | 447.00M | -104.00M |
| Cash from Operations | 2.55B | 2.13B | 1.19B | 3.46B | 2.24B |
| Capital Expenditure | -437.00M | -450.00M | -376.00M | -465.00M | -404.00M |
| Sale of Property, Plant, and Equipment | 1.00M | 4.00M | 9.00M | 27.00M | 4.00M |
| Cash Acquisitions | -5.00M | 0.00 | -8.87B | 0.00 | -4.04B |
| Divestitures | 1.02B | -- | -- | -- | -- |
| Other Investing Activities | -657.00M | 610.00M | 278.00M | 1.33B | 314.00M |
| Cash from Investing | -77.00M | 164.00M | -8.96B | 891.00M | -4.12B |
| Total Debt Issued | 0.00 | 0.00 | 5.63B | 4.92B | 1.10B |
| Total Debt Repaid | -1.11B | -389.00M | -1.41B | -1.29B | -597.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 0.00 | -1.00B | -3.00B | -37.00M | -963.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -174.00M | -175.00M | -162.00M | -162.00M | -163.00M |
| Other Financing Activities | 218.00M | -7.00M | 40.00M | 91.00M | -4.00M |
| Cash from Financing | -1.06B | -1.57B | 1.09B | 3.53B | -632.00M |
| Foreign Exchange rate Adjustments | -12.00M | 98.00M | 78.00M | -6.00M | -75.00M |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -1.00M | -- | -1.00M |
| Net Change in Cash | 1.40B | 816.00M | -6.60B | 7.87B | -2.59B |